N-Arachidonoyldopamine
Endogenous TRPV1 activator / Endogenous conjugate of arachidonic acid and dopamine.1 May be the “endogenous capsaicin like substance” in the CNS acting at TRPV1 channels, EC50~ 50 nM1. Also acts as a selective cannabinoid CB1 agonist (Ki=0.25 and 15 uM for CB1 and CB2 respectively)2 and results in a distinct signaling profile from any known cannabinoid3. Competitive inhibitor of FAAH and anadamide transport.4. Modulates acute systemic inflammation via non-hematopoietic TRPV1.5
Biochemicals & reagents
199875-69-9
NADA; AA-DA; N-Arachidonoyldopamine
1) Huang et al. (2002), An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors; Proc. Natl. Acad. Sci. USA, 99 8400 2) Bisogno et al. (2000), N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo; Biochem. J., 351 Pt 3 817 3) Redmund et al. (2016), Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors; Br. J. Pharmacol., 173 115 4) Petrocellis et al. (2000), Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity; FEBS Lett., 483 52 5) Lawton et al. (2017), N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1; J. Immunol., 199 1465
-80°C
TARGET: Ion channel -- PATHWAY: Cation channel